# Amneal Pharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed Mar 17, 2025

- Company: [Amneal Pharmaceuticals, Inc.](/companies/amrx.md) (CIK 1723128)
- Form: SCHEDULE 13D/A
- Filed: 2025-03-17
- Accepted by EDGAR: Mar 17, 2025, 16:45 ET
- Period: not reported
- Accession: 0000898432-25-000189
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1723128/000089843225000189/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1723128/000089843225000189/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1723128/000089843225000189/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 17, 2025.
Source: SEC EDGAR, the filing index for accession 0000898432-25-000189. Last ingested by Listed: Nov 10, 2026, 02:45 ET. No prices; not investment advice.